Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-049260
Filing Date
2026-04-29
Accepted
2026-04-29 16:01:02
Documents
1
Period of Report
2026-02-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1729
  Complete submission text file 0001213900-26-049260.txt   3194
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Issuer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SUITE 1 LEVEL 3, 62 LYGON STREET CARLTON SOUTH, VIC Australia 3053
Business Address
Laurita Aaron James (Reporting) CIK: 0002125949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38104 | Film No.: 26915587